Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 26: 116-124, 2006. First published April 18, 2006; doi:10.1152/physiolgenomics.00300.2005
1094-8341/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/2/116    most recent
00300.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dawson, P. A.
Right arrow Articles by Markovich, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dawson, P. A.
Right arrow Articles by Markovich, D.
Received 6 December 2005; accepted in final form 12 April 2006.
Physiological Genomics 26:116-124 (2006)
1094-8341/06 $8.00 © 2006 American Physiological Society

Transcriptional profile reveals altered hepatic lipid and cholesterol metabolism in hyposulfatemic NaS1 null mice

Paul Anthony Dawson1, Brooke Gardiner2, Sean Grimmond2 and Daniel Markovich1

1 School of Biomedical Sciences, University of Queensland, St. Lucia, Australia
2 Institute for Molecular Bioscience, University of Queensland, St. Lucia, Australia

Sulfate plays an essential role in human growth and development, and its circulating levels are maintained by the renal Na+-SO42– cotransporter, NaS1. We previously generated a NaS1 knockout (Nas1–/–) mouse, an animal model for hyposulfatemia, that exhibits reduced growth and liver abnormalities including hepatomegaly. In this study, we investigated the hepatic gene expression profile of Nas1–/– mice using oligonucleotide microarrays. The mRNA expression levels of 92 genes with known functional roles in metabolism, cell signaling, cell defense, immune response, cell structure, transcription, or protein synthesis were increased (n = 51) or decreased (n = 41) in Nas1–/– mice when compared with Nas1+/+ mice. The most upregulated transcript levels in Nas1–/– mice were found for the sulfotransferase genes, Sult3a1 ({approx}500% increase) and Sult2a2 (100% increase), whereas the metallothionein-1 gene, Mt1, was among the most downregulated genes (70% decrease). Several genes involved in lipid and cholesterol metabolism, including Scd1, Acly, Gpam, Elov16, Acsl5, Mvd, Insig1, and Apoa4, were found to be upregulated (≥30% increase) in Nas1–/– mice. In addition, Nas1–/– mice exhibited increased levels of hepatic lipid ({approx}16% increase), serum cholesterol ({approx}20% increase), and low-density lipoprotein ({approx}100% increase) and reduced hepatic glycogen ({approx}50% decrease) levels. In conclusion, these data suggest an altered lipid and cholesterol metabolism in the hyposulfatemic Nas1–/– mouse and provide new insights into the metabolic state of the liver in Nas1–/– mice.

sulfate; gene expression; liver; transporter; slc13a1







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.